Hochschulschrift
Luminescent conjugated oligothiophenes as diagnostic tools and potential pharmacophores in Alzheimer´s disease
- Weitere Titel
-
LCOs (luminescent conjugated oligothiophenes) als neue β-Amyloid-bindende Substanzen zur Diagnose und Therapie der Alzheimer´schen Erkrankung
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Berlin, Freie Universität Berlin, Diss., 2014
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Freie Universität Berlin
- (wann)
-
2014
- Urheber
-
Handrick, Susann
- URN
-
urn:nbn:de:kobv:188-fudissthesis000000097626-8
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Handrick, Susann
- Freie Universität Berlin
Entstanden
- 2014
Ähnliche Objekte (12)
Tau Protein Binding Modes in Alzheimer’s Disease for Cationic Luminescent Ligands
Development of surface-FIDA towards a diagnostic tool for Alzheimer's disease
XGBoost-SHAP-based interpretable diagnostic framework for alzheimer’s disease
Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease
Denouements of machine learning and multimodal diagnostic classification of Alzheimer’s disease
Alzheimer’s Disease
A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Alzheimer’s Disease Plasma Biomarkers Distinguish Clinical Diagnostic Groups in Memory Clinic Patients
Tau Protein Binding Modes in Alzheimer’s Disease for Cationic Luminescent Ligands
Development of surface-FIDA towards a diagnostic tool for Alzheimer's disease
XGBoost-SHAP-based interpretable diagnostic framework for alzheimer’s disease
Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease
Denouements of machine learning and multimodal diagnostic classification of Alzheimer’s disease
Alzheimer’s Disease
A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Alzheimer’s Disease Plasma Biomarkers Distinguish Clinical Diagnostic Groups in Memory Clinic Patients
Tau Protein Binding Modes in Alzheimer’s Disease for Cationic Luminescent Ligands
Development of surface-FIDA towards a diagnostic tool for Alzheimer's disease
XGBoost-SHAP-based interpretable diagnostic framework for alzheimer’s disease
Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease
Denouements of machine learning and multimodal diagnostic classification of Alzheimer’s disease
Alzheimer’s Disease
A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications